Search | OpenScholar

Search results

193 results found

Prospective validation of the first FDA-approved computer-aided quality (CAQ) assessment tool for colonoscopy: An initial clinical experience.

Publication: Journal Article

Brenner, Todd A, Chris Labaki, Joseph D Feuerstein, and Tyler M Berzin. 2025. “Prospective Validation of the First FDA-Approved Computer-Aided Quality (CAQ) Assessment Tool for Colonoscopy: An Initial Clinical Experience.”. The American Journal of Gastroenterology.

Proactive Compared to Reactive Therapeutic Drug Monitoring Is Associated with Less Treatment Failure in Patients with Inflammatory Bowel Disease Treated with Adalimumab.

Publication: Journal Article

Gade, Ajay, Alessandra Saraga, Tina Deyhim, Grace Geeganage, Samantha Zullow, Loren G Rabinowitz, Laurie B Grossberg, Adam S Cheifetz, and Konstantinos Papamichael. 2025. “Proactive Compared to Reactive Therapeutic Drug Monitoring Is Associated With Less Treatment Failure in Patients With Inflammatory Bowel Disease Treated With Adalimumab.”. Digestive Diseases and Sciences.

Therapeutic drug monitoring for de-escalating anti-tumor necrosis factor therapy in patients with inflammatory bowel disease.

Publication: Journal Article

Gade, Ajay, Alessandra Saraga, Alfonso Elosua, Antony Ishan, Tina Deyhim, Nathan David Vanshelboym Rothschild, Adam S Cheifetz, and Konstantinos Papamichael. 2026. “Therapeutic Drug Monitoring for De-Escalating Anti-Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease.”. Expert Review of Clinical Pharmacology 19 (2): 167-74.